Democratizing complex cardiac and brain stroke interventions with AI-driven mini-robotics
At Carvolix, we are transforming cardiac valve replacement and ischemic stroke treatment. We focus on conditions with large unmet clinical need and limited patient access to effective therapy.
Our Portfolio
At Carvolix, we are transforming cardiac valve replacement and ischemic stroke treatment.
Carvolix develops AI- and imaging-driven mini-robotic technologies designed to expand access to these life-saving procedures. Our platform supports interventional cardiologists in complex procedures, where precision, consistency, and speed are critical.
Our mini-robots operate with supervised autonomy, guided by real-time imaging and artificial intelligence. By assisting with navigation and positioning, they help clinicians manage the most technically demanding steps of valve and stroke interventions, with the goal of improving procedural efficiency, safety, and patient outcomes.
By empowering interventional cardiologists, far more numerous than surgeons and interventional neuroradiologists, and highly receptive to innovation, we expand patients’ access to advanced procedures. Our platform enables a broader base of physicians to perform complex interventions with greater precision, confidence, and reproducibility, ultimately accelerating patient access to life-saving therapies.
World First Autopilot Solutions for Heart & Brain Procedures
Heart Valve Replacement
17% of eligible patients receive TAVI
4% of patients with severe mitral regurgitation undergo surgery
Stroke Treatment
Less than 5% of ischemic stroke patients have access to mechanical thrombectomy
2nd cause of death • 1st cause of acquired handicap
Press Releases & Articles
Carvolix Appoints Anne Lange as Chair of its Board of Directors Confirming the Acceleration of its Ambitions and Reports 2026 Half-Year Results
Carvolix Appoints Anne Lange as Chair of its Board of Directors Confirming the Acceleration of its Ambitions and Reports 2026 Half-Year Results
30 september 2026
Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform
Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform
22 september 2026
Carvolix Takes a Key Step Toward Commercial Launch of TAVIPILOT Software in Europe with Regulatory Submission for CE Marking
Carvolix Takes a Key Step Toward Commercial Launch of TAVIPILOT Software in Europe with Regulatory Submission for CE Marking
09 september 2026